Market Overview:
The global expression vectors market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for gene therapy and rising prevalence of chronic diseases. In addition, the increasing use of expression vectors in research and development activities is also contributing to the growth of this market. On the basis of type, bacterial expression vectors accounted for the largest share in 2017 and are expected to continue its dominance during the forecast period. This can be attributed to their high efficiency, low cost, easy production process, and wide applicability across various industries.
Product Definition:
An expression vector is a sequence of DNA, RNA or protein that is used to clone or amplify a gene. Expression vectors are important for genetic engineering and molecular biology because they allow scientists to clone genes and produce large quantities of the gene's product.
Bacterial:
Bacterial is a generic name for all single-cell organisms, including bacteria, archaea, and eukaryotic microbes. Bacteria are ubiquitous in nature and can be found in almost every niche environment on the earth. They play an important role in nutrient cycles (e.g., decomposition of organic matter), climate regulation (e.g., production of clouds), and protection against predation (e.g., producing antibacterial substances).
Mammalian:
Mammalian is a category of expression vectors used for the stable transformation of mammalian cells. The main function of these vectors is to carry genes from one place to another place in the cell where they are supposed to be?the gene expression is under control and it will do its job.?It has been observed that most human diseases are caused due to mutations in single nucleotide polymorphism (SNP) regions, which occur in protein-coding regions.
Application Insights:
The application of expression vectors in genomics, molecular biology and bioinformatics is expected to witness significant growth over the forecast period. The growing adoption of these vectors for genetic analysis owing to their ability to introduce DNA into cells is anticipated to drive this segment. In addition, the increasing use of these products for research purposes including transgenic animals and cell-based studies is projected to fuel demand over the next eight years.
Expression vector-based methods have also been used extensively in unmet medical needs areas such as cardiovascular disease, respiratory diseases and diabetes mellitus type II. These products are being increasingly used for drug screening against a large number of compounds with high specificity and efficiency due largelyto their ability to transform mammalian cells with high efficiency.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. This can be attributed to the presence of a large number of vector developers and manufacturers coupled with high adoption rates for new technologies across this region. Moreover, increasing R&D investments by government agencies and academic institutes are also driving the growth of this industry within North America.
Growth Factors:
- Increasing demand for genetically modified crops
- Rising prevalence of target diseases
- Technological advancements in vector development and delivery systems
- Growing number of collaborations and partnerships between biotechnology companies and research institutes
- Rising investment in the field of gene therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Expression Vectors Market Research Report
By Type
Bacterial, Mammalian, Yeast, Insect
By Application
Genetics, Molecular biology, Bioinformatics, Unmet medical needs
By Companies
Promega, Agilent, Thermo Fisher, Bio-Rad, Merck Millipore, QIAGEN, Takara Bio, ATUM, New England Biolabs, Sigma-Aldrich, GenScript
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Expression Vectors Market Report Segments:
The global Expression Vectors market is segmented on the basis of:
Types
Bacterial, Mammalian, Yeast, Insect
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Genetics, Molecular biology, Bioinformatics, Unmet medical needs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Promega
- Agilent
- Thermo Fisher
- Bio-Rad
- Merck Millipore
- QIAGEN
- Takara Bio
- ATUM
- New England Biolabs
- Sigma-Aldrich
- GenScript
Highlights of The Expression Vectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bacterial
- Mammalian
- Yeast
- Insect
- By Application:
- Genetics
- Molecular biology
- Bioinformatics
- Unmet medical needs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Expression Vectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Expression vectors are a type of vector that can be used to express genes in a particular way. Expression vectors are often used to introduce new genes into cells, and they can also be used to study the effects of genes on the cell.
Some of the major players in the expression vectors market are Promega, Agilent, Thermo Fisher, Bio-Rad, Merck Millipore, QIAGEN, Takara Bio, ATUM, New England Biolabs, Sigma-Aldrich, GenScript.
The expression vectors market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Expression Vectors Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Expression Vectors Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Expression Vectors Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Expression Vectors Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Expression Vectors Market Size & Forecast, 2020-2028
4.5.1 Expression Vectors Market Size and Y-o-Y Growth
4.5.2 Expression Vectors Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bacterial
5.2.2 Mammalian
5.2.3 Yeast
5.2.4 Insect
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Genetics
6.2.2 Molecular biology
6.2.3 Bioinformatics
6.2.4 Unmet medical needs
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Expression Vectors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Expression Vectors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bacterial
9.6.2 Mammalian
9.6.3 Yeast
9.6.4 Insect
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Genetics
9.10.2 Molecular biology
9.10.3 Bioinformatics
9.10.4 Unmet medical needs
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bacterial
10.6.2 Mammalian
10.6.3 Yeast
10.6.4 Insect
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Genetics
10.10.2 Molecular biology
10.10.3 Bioinformatics
10.10.4 Unmet medical needs
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bacterial
11.6.2 Mammalian
11.6.3 Yeast
11.6.4 Insect
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Genetics
11.10.2 Molecular biology
11.10.3 Bioinformatics
11.10.4 Unmet medical needs
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bacterial
12.6.2 Mammalian
12.6.3 Yeast
12.6.4 Insect
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Genetics
12.10.2 Molecular biology
12.10.3 Bioinformatics
12.10.4 Unmet medical needs
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bacterial
13.6.2 Mammalian
13.6.3 Yeast
13.6.4 Insect
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Genetics
13.10.2 Molecular biology
13.10.3 Bioinformatics
13.10.4 Unmet medical needs
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Expression Vectors Market: Competitive Dashboard
14.2 Global Expression Vectors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Promega
14.3.2 Agilent
14.3.3 Thermo Fisher
14.3.4 Bio-Rad
14.3.5 Merck Millipore
14.3.6 QIAGEN
14.3.7 Takara Bio
14.3.8 ATUM
14.3.9 New England Biolabs
14.3.10 Sigma-Aldrich
14.3.11 GenScript
